Literature DB >> 31236082

Reversible Cerebral Vasoconstriction Syndrome Associated with Coronary Artery Vasospasm.

Rida Laeeq, Jeffrey S Berman, Umair Khalid, Nasser M Lakkis, Rashed Tabbaa.   

Abstract

Reversible cerebral vasoconstriction syndrome is a rare disorder associated with neurologic symptoms secondary to diffuse cerebral vasospasm. Cardiac involvement in this disease is exceedingly rare. A 50-year-old woman was admitted to our hospital for evaluation of chest pain. During a 3-year period, she had been admitted multiple times because of chest pain and elevated serum cardiac enzymes. Transthoracic echocardiograms showed transient wall-motion abnormalities; however, coronary angiograms revealed no coronary artery disease. At the current admission, she had a thunderclap headache, and cerebral angiograms revealed diffuse cerebral vasoconstriction that improved after verapamil infusion, confirming the diagnosis of reversible cerebral vasoconstriction syndrome. The patient was treated successfully with oral diltiazem and had no recurrence of symptoms. We describe what we think is the first reported case of coronary artery spasm in association with reversible cerebral vasoconstriction syndrome. Future research should be focused on identifying treatment options and defining the mechanisms by which the cerebral and coronary vasculature are affected.

Entities:  

Keywords:  Cardiomyopathies/diagnosis; cerebral arterial diseases/complications/diagnostic imaging; cerebrovascular circulation/drug effects/physiology; headache disorders, primary/diagnosis/etiology; time factors; treatment outcome; vasoconstriction; vasodilator agents/therapeutic use

Year:  2019        PMID: 31236082      PMCID: PMC6555287          DOI: 10.14503/THIJ-17-6403

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  2 in total

1.  Reversible cerebral vasoconstriction syndrome with cardiac involvement during treatment for iron deficiency anemia: caser report.

Authors:  Kenya Oguchi; Kazuhiro Fukushima; Akinori Nakamura; Yo-Ichi Takei
Journal:  BMC Neurol       Date:  2021-12-10       Impact factor: 2.474

Review 2.  Pathophysiology of reversible cerebral vasoconstriction syndrome.

Authors:  Shih-Pin Chen; Shuu-Jiun Wang
Journal:  J Biomed Sci       Date:  2022-09-21       Impact factor: 12.771

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.